Proceedings of the Texas A&M Medical Student Grand Rounds

The association of STAT3, the Mediterranean diet, and colorectal cancer risk

July 9, 2018 Cory Ziegler

Cory Ziegler

Colorectal cancer (CRC) is the third most common cause of cancer and the fourth most common cancer-related death worldwide. Risk factors for developing CRC include age, chronic disease history, physical activity, and diet. As mutations accumulate, normal colon and rectal mucosa can develop into adenomatous polyps and further develop into carcinoma, resulting in uncontrolled cell growth and clonal tumor development. Sporadic CRC accounts for approximately 70% of cases. Methods to reduce the occurrence of sporadic CRC are currently under investigation.1 One such method is to decrease the risk of developing CRC by changing dietary habits. Multiple epidemiological studies have shown that individuals who adhere to a Mediterranean diet have a decreased risk for developing CRC.2,3 Emerging evidence indicates that polyunsaturated fatty acids (PUFAs) may have a role in epigenetically modifying the regulation of the genes involved in cancer development.4 Specifically, the Mediterranean diet has a higher ratio of ω-3: ω-6 PUFAs compared to the standard Western diet. The benefit of this dietary change has been demonstrated using mice susceptible to adenomatous polyps, APC (min/+). Feeding these mice a diet with a higher ω-3: ω-6 PUFA ratio resulted in a decreased number and volume of adenomatous polyps.5 It is believed that this result is correlated with decreased expression of IL-6 and subsequent downregulation of the STAT3 pathway. The STAT3 pathway is a JAK/STAT pathway leading to the expression of multiple anti-apoptotic proteins.6,7 APC (min/+) mice fed a high ω-3: ω-6 PUFA diet had decreased expression of activated p-STAT3, resulting in less expression of the STAT3 pathway. As expected, these mice with reduced expression of the STAT3 pathway have decreased concentrations of anti-apoptotic proteins, especially BCL-2.5 The STAT3 pathway can be activated by various growth factors and cytokines, such as IL-6. An analytical study combined population and in vitro studies to investigate the relationship between ω-3 PUFA and IL-6 expression. They found that higher concentrations of circulating ω-3 PUFA led to decreased methylation of the IL6 promoter cg01770232 and consequently decreased concentrations of circulating IL-6.4 At the moment it is still unclear how ω-3 PUFAs directly affect these epigenetic changes.8 These studies indicate that a possible anti-tumorigenic mechanism of the Mediterranean diet in the colon and rectum correlates with its high ω-3 PUFA: ω-6 PUFA ratio, leading to decreased IL-6 concentrations via epigenetic changes, and subsequent decreased expression of anti-apoptotic proteins through the STAT3 pathway.

 

  1. Mármol al. Colorectal carcinoma: A general overview and future perspectives in colorectal cancer. Int J Mol Sci (2017) 18, 197.
  2. Farinetti al. Mediterranean diet and colorectal cancer: A systematic review. Nutrition (2017) 43-44:83-88.
  3. Donovan al. Mediterranean diet: Prevention of colorectal cancer. Front Nutr (2017) 4:59.
  4. Ma al. The effects of omega-3 polyunsaturated fatty acids and genetic variants on methylation levels of the interleukin-6 gene promoter. Mol Nutr Food Res (2016) 60:410–419.
  5. Barone al. Olive oil and omega-3 polyunsaturated fatty acids suppress intestinal polyp growth by modulating the apoptotic process in APC(Min/+) mice. Carcinogenesis (2014) 35, 7:1613–1619.
  6. Huang al. Regulation of Metastases by Signal Transducer and Activator of Transcription 3 Signaling Pathway: Clinical Implications. Clin Cancer Res(2007) 13, 5:1362-6.
  7. Corvinus al. Persistent STAT3 Activation in Colon Cancer Is Associated with Enhanced Cell Proliferation and Tumor Growth. Neoplasia (2005) 7, 6:545 – 555.
  8. Burdge GC. Polyunsaturated Fatty Acid Metabolism. Elsevier (2018) 225-238.
Cancer
Previous Post

The Role of Brain Derived Neurotrophic Factor (BDNF) in Cocaine Addiction

Next Post

Role of Twist1-Induced Epithelial-to-Mesenchymal Transition in Upregulating ABC Transporters Driving Multi-Drug Resistance in colon cancer

Scientific Editors

Steve A. Maxwell

Executive Editor
Tel: 979-436-0804
smaxwell@medicine.tamhsc.edu

Robin Fuchs-Young

Deputy Editor
Tel: 979-845-5109
fuchs-young@medicine.tamhsc.edu
Administrative Editor

Janis Chmiel

Tel: 979-436-0856
chmiel@medicine.tamhsc.edu
Editorial Office
Tel.: 979-845-2726
Fax: 979-847-9481
chmiel@medicine.tamhsc.edu
Archives
  • July 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • May 2025
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • August 2022
  • June 2022
  • May 2022
  • August 2021
  • July 2021
  • April 2021
  • October 2020
  • August 2020
  • July 2020
  • August 2019
  • July 2019
  • February 2019
  • July 2018
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • January 2017
Proudly powered by WordPress | Theme: Fmi by Forrss.